Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 24 |
| Dec 2025 | 0 | 6 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 4 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2019 Filed Mar 18, 2019 20:55 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 3,866 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000082 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,911 F2 · shares: Represents performance stock units granted on March 12, 2018 and earned at approximately 80% of target based on 2018 adjusted EBITDA. Fifty percent (50%) were issued on March 14, 2018. The remaining shares earned in connection with the March 2018 grant will vest and be issued as follows: 50% on 03/12/2020, and 50% on 03/12/2021, assuming continued employment on the relevant vesting date. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:55 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 2 | $29.70 | $59.40 |
DisclosureSEC source: 0000784199-19-000082 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,045 F1 · shares: This is an adjustment to the shares withheld for taxes for the 3/1/2019 PSU Vesting. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:51 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 466 | $28.92 | $13,476.72 |
DisclosureSEC source: 0000784199-19-000076 · certent-form4.xml · nonDerivative · entry 3 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,079 F3 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:51 UTC |
Capps Scott BVP, Clinical Research
|
GrantCommon Stock | 3,092 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000076 · certent-form4.xml · nonDerivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,545 F2 · shares: Represents performance stock units granted on March 12, 2018 and earned at approximately 80% of target based on 2018 adjusted EBITDA. Fifty percent (50%) were issued on March 14, 2018. The remaining shares earned in connection with the March 2018 grant will vest and be issued as follows: 50% on 03/12/2020, and 50% on 03/12/2021, assuming continued employment on the relevant vesting date. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:51 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 2 | $29.70 | $59.40 |
DisclosureSEC source: 0000784199-19-000076 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,453 F1 · shares: This is an adjustment to the shares withheld for taxes for the 3/1/2019 PSU Vesting. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:48 UTC |
Bogenschuetz Thomas JVP, EMEA & General Manager
|
Tax withholdingCommon Stock | 735 | $28.92 | $21,256.20 |
DisclosureSEC source: 0000784199-19-000073 · certent-form4.xml · nonDerivative · entry 2 Bogenschuetz Thomas J · CIK 0001742273 · VP, EMEA & General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,615 F2 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 14, 2019 Filed Mar 18, 2019 20:48 UTC |
Bogenschuetz Thomas JVP, EMEA & General Manager
|
GrantCommon Stock | 3,092 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000073 · certent-form4.xml · nonDerivative · entry 1 Bogenschuetz Thomas J · CIK 0001742273 · VP, EMEA & General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,350 F1 · shares: Represents performance stock units granted on March 12, 2018 and earned at approximately 80% of target based on 2018 adjusted EBITDA. Fifty percent (50%) were issued on March 14, 2018. The remaining shares earned in connection with the March 2018 grant will vest and be issued as follows: 50% on 03/12/2020, and 50% on 03/12/2021, assuming continued employment on the relevant vesting date. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 23:10 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,666 | $6.12 Strike: $6.12 | $40,795.92 |
DisclosureSEC source: 0000784199-19-000071 · certent-form4.xml · derivative · entry 3 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,666 shares Expires 2020-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was 2/15/2014 Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 23:10 UTC |
Horton AmyVP, Chief Accounting Officer
|
SaleCommon Stock | 6,666 | $29.15 | $194,298.57 |
DisclosureSEC source: 0000784199-19-000071 · certent-form4.xml · nonDerivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,047 F1 · price: Reflects weighted average price. Range was between $29.10 - $25.19. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. Read SEC document |
| March 06, 2019 Filed Mar 8, 2019 23:10 UTC |
Horton AmyVP, Chief Accounting Officer
|
Exercise / conversionCommon Stock | 6,666 | $6.12 | $40,795.92 |
DisclosureSEC source: 0000784199-19-000071 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,713 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:55 UTC |
Davis John ESenior VP, Global Sales
|
GrantStock Option (Right to Buy) · Derivative | 12,787 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000064 · certent-form4.xml · derivative · entry 2 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,787 Underlying: Common Stock · 12,787 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:55 UTC |
Davis John ESenior VP, Global Sales
|
GrantCommon Stock | 4,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000064 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,757 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:56 UTC |
Capps Scott BVP, Clinical Research
|
GrantStock Option (Right to Buy) · Derivative | 7,265 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000066 · certent-form4.xml · derivative · entry 2 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,265 Underlying: Common Stock · 7,265 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:56 UTC |
Capps Scott BVP, Clinical Research
|
GrantCommon Stock | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000066 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,455 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:53 UTC |
Holloway Jean FVP, General Counsel
|
GrantStock Option (Right to Buy) · Derivative | 12,787 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000062 · certent-form4.xml · derivative · entry 2 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,787 Underlying: Common Stock · 12,787 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:53 UTC |
Holloway Jean FVP, General Counsel
|
GrantCommon Stock | 4,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000062 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,323 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:52 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantStock Option (Right to Buy) · Derivative | 7,992 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000060 · certent-form4.xml · derivative · entry 2 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,992 Underlying: Common Stock · 7,992 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:52 UTC |
Horton AmyVP, Chief Accounting Officer
|
GrantCommon Stock | 3,095 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000060 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,047 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:48 UTC |
Maier Dennis BVice President, Operations
|
GrantStock Options (Right to Buy) · Derivative | 7,265 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000054 · certent-form4.xml · derivative · entry 2 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,265 Underlying: Common Stock · 7,265 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:48 UTC |
Maier Dennis BVice President, Operations
|
GrantCommon Stock | 2,813 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000054 · certent-form4.xml · nonDerivative · entry 1 Maier Dennis B · CIK 0001742150 · Vice President, Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,943 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:51 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantStock Option (Right to Buy) · Derivative | 15,257 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000058 · certent-form4.xml · derivative · entry 3 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,257 Underlying: Common Stock · 15,257 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:51 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
GrantCommon Stock | 5,908 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000058 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 278,469 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:49 UTC |
Mackin James PPresident & CEO
|
GrantStock Option (Right to Buy) · Derivative | 61,842 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000056 · certent-form4.xml · derivative · entry 2 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,842 Underlying: Common Stock · 61,842 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:49 UTC |
Mackin James PPresident & CEO
|
GrantCommon Stock | 23,948 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000056 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 252,541 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:45 UTC |
McDermid James MSVP, CHRO
|
GrantStock Option (Right to Buy) · Derivative | 11,625 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000052 · certent-form4.xml · derivative · entry 2 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,625 Underlying: Common Stock · 11,625 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:45 UTC |
McDermid James MSVP, CHRO
|
GrantCommon Stock | 4,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000052 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,603 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:43 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
GrantStock Option (Right to Buy) · Derivative | 11,625 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000048 · certent-form4.xml · derivative · entry 2 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,625 Underlying: Common Stock · 11,625 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 02:43 UTC |
Simpson Michael SSVP, Regulatory Affairs and QA
|
GrantCommon Stock | 4,501 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000048 · certent-form4.xml · nonDerivative · entry 1 Simpson Michael S · CIK 0001760902 · SVP, Regulatory Affairs and QA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,523 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 15:23 UTC |
Bogenschuetz Thomas JVP, EMEA & General Manager
|
GrantStock Options (Right to Buy) · Derivative | 12,787 | $0.00 Strike: $29.62 | $0.00 |
DisclosureSEC source: 0000784199-19-000069 · certent-form4.xml · derivative · entry 2 Bogenschuetz Thomas J · CIK 0001742273 · VP, EMEA & General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,787 Underlying: Common Stock · 12,787 shares Expires 2026-03-05 F2 · derivative.exercise_date: Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. Read SEC document |
| March 05, 2019 Filed Mar 8, 2019 15:23 UTC |
Bogenschuetz Thomas JVP, EMEA & General Manager
|
GrantCommon Stock | 4,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000784199-19-000069 · certent-form4.xml · nonDerivative · entry 1 Bogenschuetz Thomas J · CIK 0001742273 · VP, EMEA & General Manager 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,258 F1 · shares: Represents share of restricted stock that vest on the third anniversary of the grant date if the reporting person remains in the continuous employ of the Company. Read SEC document |
| March 02, 2019 Filed Mar 8, 2019 02:44 UTC |
Saurini Sherry MVP, Quality
|
Tax withholdingCommon Stock | 1,388 | $29.70 | $41,223.60 |
DisclosureSEC source: 0000784199-19-000050 · certent-form4.xml · nonDerivative · entry 1 Saurini Sherry M · CIK 0001666007 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,460 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 13:26 UTC |
Saurini Sherry MVP, Quality
|
Tax withholdingCommon Stock | 778 | $29.70 | $23,106.60 |
DisclosureSEC source: 0000784199-19-000046 · certent-form4.xml · nonDerivative · entry 1 Saurini Sherry M · CIK 0001666007 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,848 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 13:19 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 8,103 | $29.70 | $240,659.10 |
DisclosureSEC source: 0000784199-19-000041 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,593 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 13:22 UTC |
McDermid James MSVP, CHRO
|
Tax withholdingCommon Stock | 501 | $29.70 | $14,879.70 |
DisclosureSEC source: 0000784199-19-000044 · certent-form4.xml · nonDerivative · entry 1 McDermid James M · CIK 0001681601 · SVP, CHRO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,102 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 13:17 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 2,015 | $29.70 | $59,845.50 |
DisclosureSEC source: 0000784199-19-000039 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 272,561 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 13:13 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,133 | $29.70 | $33,650.10 |
DisclosureSEC source: 0000784199-19-000037 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,952 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 13:08 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 1,506 | $29.70 | $44,728.20 |
DisclosureSEC source: 0000784199-19-000034 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,371 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 13:05 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 1,485 | $29.70 | $44,104.50 |
DisclosureSEC source: 0000784199-19-000032 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,805 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| March 01, 2019 Filed Mar 4, 2019 13:03 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 1,087 | $29.70 | $32,283.90 |
DisclosureSEC source: 0000784199-19-000030 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,642 F1 · shares: These shares were withheld upon the vesting of performance stock units to pay tax withholding obligations. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 00:53 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 1,103 | $29.38 | $32,406.14 |
DisclosureSEC source: 0000784199-19-000028 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 274,576 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 22, 2019 Filed Feb 26, 2019 00:51 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 882 | $29.38 | $25,913.16 |
DisclosureSEC source: 0000784199-19-000024 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,877 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 21, 2019 Filed Feb 26, 2019 00:52 UTC |
McCall Ronald DDirector
|
SaleCommon Stock | 6,200 | $29.26 | $181,389.68 |
DisclosureSEC source: 0000784199-19-000026 · certent-form4.xml · nonDerivative · entry 1 McCall Ronald D · CIK 0001016766 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,699 F1 · price: Reflects weighted average price. Range of prices were between $29.13 to $25.28. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:28 UTC |
Capps Scott BVP, Clinical Research
|
Tax withholdingCommon Stock | 2,358 | $28.84 | $68,004.72 |
DisclosureSEC source: 0000784199-19-000018 · certent-form4.xml · nonDerivative · entry 1 Capps Scott B · CIK 0001409753 · VP, Clinical Research 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,729 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:30 UTC |
Saurini Sherry MVP, Quality
|
Tax withholdingCommon Stock | 1,760 | $28.84 | $50,758.40 |
DisclosureSEC source: 0000784199-19-000022 · certent-form4.xml · nonDerivative · entry 1 Saurini Sherry M · CIK 0001666007 · VP, Quality 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,626 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:29 UTC |
Horton AmyVP, Chief Accounting Officer
|
Tax withholdingCommon Stock | 2,368 | $28.84 | $68,293.12 |
DisclosureSEC source: 0000784199-19-000020 · certent-form4.xml · nonDerivative · entry 1 Horton Amy · CIK 0001371523 · VP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,085 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:27 UTC |
Davis John ESenior VP, Global Sales
|
Tax withholdingCommon Stock | 2,941 | $28.84 | $84,818.44 |
DisclosureSEC source: 0000784199-19-000016 · certent-form4.xml · nonDerivative · entry 1 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,290 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:26 UTC |
Holloway Jean FVP, General Counsel
|
Tax withholdingCommon Stock | 2,933 | $28.84 | $84,587.72 |
DisclosureSEC source: 0000784199-19-000014 · certent-form4.xml · nonDerivative · entry 1 Holloway Jean F · CIK 0001540065 · VP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,759 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:25 UTC |
LEE DAVID ASHLEYExecutive VP, COO & CFO
|
Tax withholdingCommon Stock | 4,053 | $28.84 | $116,888.52 |
DisclosureSEC source: 0000784199-19-000012 · certent-form4.xml · nonDerivative · entry 1 LEE DAVID ASHLEY · CIK 0001112830 · Executive VP, COO & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,679 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| February 19, 2019 Filed Feb 21, 2019 22:24 UTC |
Mackin James PPresident & CEO
|
Tax withholdingCommon Stock | 6,602 | $28.84 | $190,401.68 |
DisclosureSEC source: 0000784199-19-000010 · certent-form4.xml · nonDerivative · entry 1 Mackin James P · CIK 0001408470 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,696 F1 · shares: Represent shares of restricted stock that were withheld for taxes on the grant vest date. Read SEC document |
| January 01, 2019 Filed Aug 5, 2019 13:05 UTC |
Davis John ESenior VP, Global Sales
|
GrantESPP · Derivative | 880 | $24.12 Strike: $24.12 | $21,228.24 |
DisclosureSEC source: 0000784199-19-000143 · certent-form5.xml · derivative · entry 3 Davis John E · CIK 0001653206 · Senior VP, Global Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 880 Underlying: Common Stock · 880 shares Expires 2019-06-30 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.